Objective: To determine the differences between human immunodeficiency virus (HIV-infected and non-HIV-infected patients with pneumococcal bacteremia.
Pneumococcal infection causes significant morbidity and mortality, especially in certain risk groups.A recent community-based study has shown a rise in the incidence of pneumococcal bacteremia.l The highest reported annual incidence of pneumococcal bacteremia is 207 per 100,000 population, in the White Mountain Apache Native Indians.' The annual incidence of pneumococcal bacteremia is calculated to be as high as 940 per 100,000 patients with acquired immunodeficiency syndrome (AIDS). 3 The present study aims to describe the differences in clinical presentation, hospital course, and outcome between human immunodeficiency virus (HIV)-infected and non-HIV-infected patients with pneumococcal bacteremia.
PATIENTS AND METHODS
This study was a retrospective chart review conducted at Howard University Hospital, a 500-bed inner-city teaching hospital located in Washington, DC.The hospital's patients are predominantly African-American, of low socioeconomic status.Testing for HIV antibody both by enzymelinked immunosorbent assay (ELISA) and Western blot was available to patients since April 1985. In the lo-year period fromApril 1985 to April 1995,393 cases of pneumococcal bacteremia were identified from microbiology logs. Excluding 71 children under 16 years of age and 128 adults whose HIV status was unknown, 194 cases of pneumococcal bacteremia in 184 patients with known HIV status were included in this study. For the purpose of this study each case was considered as one patient.
Data collected included patients' age, sex, race, risk factors for pneumococcal infection, status of pneumococcal vaccination, initial vital signs, laboratory values, source of bacteremia, and in-hospital complications as previously described.* In an earlier study, a severity grading system was developed, which showed that older age, lower mean arterial pressure, lower temperature, higher respiratory rate, and lower leukocyte count were associated with increased mortality in patients with pneumococcal bacteremia.* This system was used in the present 21 / Volume 2, Number 1, July 1997 study to categorize each patient's severity of illness as mild, moderate, or severe. Conditions that indicated AIDS were defmed according to the 1993 revised Centers for Disease Control and Prevention (CDC) criteria. 5 All means are expressed with standard deviation. For comparison between groups, unpaired Student's t-test was used for normally distributed continuous variables, Mann-Whitney U test for abnormally distributed continuous variables; cm-square test for nominal variables; and Fisher's exact test for nominal variables when any one cell of a 2 X 2 table contained less than five members. All statistical analyses were performed on Abacus Concepts, StatView software, version 4.5 (Abacus Concepts, Inc., Berkeley, CA).A P-value of less than 0.05 was considered significant.
RESULTS
Forty-one percent (79/194) of the patients included in the study had HIV infection and 115 were HIV negative. The demographic data of the patients, their pneumococcal vaccination status, and the place of acquisition and source of bacteremia are listed in Table 1 . Fifty-one (58%) of the 88 patients under 40 years of age had HIV infection. The common risk factors for pneumococcal infection in patients without HIV infection were alcohol abuse (n = 50) chronic obstructive pulmonary disease (COPD) (n = 15) and malignancy (n = 13). Seven (6%) of the 115 patients without HIV infection and 37 (47%) of the 79 patients with HIV infection were injection drug users. Sixteen patients with HN infection had a history of alcohol abuse. Risk factors for HIV infection included injection drug use (n = 31) homosexuality (n = 26) heterosexual contact (n = S), blood transfusion (n = l), homosexuality and injection drug use (n = 6) heterosexual contact and blood transfusion (n = 3) and unidentified (n = 4). Thirty (33%) of the 91 patients who developed pneumococcal bacteremia in the first 5 years of the study period had HIV infection compared to 49 (48%) of 103 patients in the second 5-year period (P = 0.0388).
The initial vital signs, selected laboratory values, and chest roentgenogram findings were available in 76 patients with HIV and 111 patients without HIV infection. The differences in these values between the two groups are listed in Table 2 . Four percent of the HIV-infected patients had a temperature less than 36.l"C at presentation compared to 7% of the non-HIV-infected patients (P = 0.5294). Seventy-one percent of the HIV-infected patients had a temperature higher than 37.8"C at presentation compared to 61% of the non-HIV-infected patients (P = 0.1538). Sixteen percent of the HIV-infected patients had a white blood cell count (WBC) count less than 3.5 X 103/mm3 at presentation compared to 7% of the non-HIV-infected patients (P = 0.0653). Fifty percent of the HIV-infected patients had a WBC count higher than 10 X 103/mm3 at presentation compared to 59% of the non-HIV-infected patients (P = 0.2202)The disease severity was mild in 54%, moderate in 39%, and severe in 7% of the HIV-infected patients compared to 44%, 45%, and 11% respectively of the non-HIV-infected patients (P = 0.3353).
Two episodes of pneumococcal bacteremia were seen in each of two patients without HIV infection compared to two episodes in each of four, and three episodes in each of two patients with HIV infection in the study period.The recurrence rate of pneumococcal bacteremia was 8.5% (6/71) in patients with HIV infection compared to 1.8% (2/l 13) in those without HIV infection (P = O.O565).The median duration of hospital stay was 13 days for both groups (P = 0.9419).The 32% (25/79) intensive care unit (ICU) admission rate for the HIV-infected patients was lower than the 50% (57/115) rate for the non-HIV-patients (P = 0.0130). In-hospital complication rates were available in 187 patients and are listed inTable 3.Thirty-four (45%) of 76 patients with HIV infection had at least one of the listed complications compared to 60 (54%) of 111 patients without HIV infection (P = 0.2 107). The in-hospital case fatality rate was 25% @O/79) for patients with HIV infection compared to 31% (36/l 15) for patients without HIV infection (P = 0.3658)The time of death following bacteremia and causes of death were not significantly different between the two groups ( Table 4) .
Forty-two (53%) of the 79 patients with HIV infection had AIDS-indicator conditions by the time of the pneumococcal bacteremia. There were no significant differences in age, initial vital signs, initial arterial blood gas values, and chest roentgenogram findings between .9 X 103/mm3, median 7.6 vs. 11.7, P = 0.0020) and the serum albumin level (2.3 + 0.5 g/dL vs. 2.7 + 0.8 g/dL, P = 0.0107) were lower in patients with AIDS than in HIV-infected patients without AIDS.The complication and ICU admission rates were similar for patients with AIDS and HIV-infected patients withoutAIDS.The median duration of hospital stay was 17 days for patients with AIDS compared to 11 days for HIV-infected patients without AIDS (P = 0.0204). Eleven (26%) of the 42 patients with AIDS died compared to 9 (24%) of the 37 HIVinfected patients without AIDS (P = 0.8490). The CD4 count was available in 63 patients with HIV infection; 49 survivors and 14 nonsurvivors. The median CD4 count was 23O/l~,L in survivors compared to 82/l~,L in nonsurvivors (P = 0.1000).
DISCUSSIONS
Most of the opportunistic infections seen in patients with HIV infection are associated with a CD4+ T-lymphocyte count below 20O/l~,L. Humoral immune dysfunction, depressed IgA2 and IgG2 levels, and decreased CD4 + T cell mediated antibody dependent cellular cytotoxicity are also present in HIV-infected patients and predispose them to pyogenic bacterial infections, including Streptococcus pneumoniae."-8
Studies in Africa have shown that lifethreatening bacteremia predominantly due to Salmonella species and S.pneumoniae are common in hospitalized HIV-l seropositive patients.9 Increased bacterial infections were described in the United States as early as the mid-1980~.~~-'~ The incidence of pneumococcal bacteremia in AIDS patients is estimated to be 100 times higher than that reported in most community-based studies in the United States.3 In a retrospective study of 283 adults with sickle-cell disease over a Gyear period, pneumococcal bacteremia was found in four of eight HIV-infected patients compared with 1 of 275 non-HIV-infected patients (P < 0.0001). 13 Recognizing the importance of bacterial infections in patients with HIV infection, the CDC has added recurrent bacterial pneumonia as one of the AIDSindicator conditions.5
Although alcohol abuse has been found to be the most common risk factor for pneumococcal infection by many investigators, HIV infection has emerged as another common risk factor.r4 In one study from New York City, 50% of the patients with pneumococcal bacteremia and pneumonia had HIV infection. 15 In another study, from Spain, 72% of the patients under 40 years of age with pneumococcal pneumonia were HIV infected. 16 Injection drug use, with or without HIV infection, is another risk factor for pneumococcal disease. 14z1' Pneumococcal bacteremia is more common inAfrican-Americans.1~18 Despite being a minority, the number of Black patients reported to have AIDS in the United States was equal to that of White patients in 1995." Since Howard University Hospital serves predominantly an inner-city, African-American population, the fmding that HIV infection was present in the majority of patients under 40 years of age is not surprising.The higher proportion of HIV-infected patients in the later years of the study most probably reflects the increasing prevalence of HIV infection.
Although uncommon, recurrent episodes of pneumococcal bacteremia have been reported in immunocompromised patients. [20] [21] [22] In the study by Redd and colleagues, the recurrence rate of invasive pneumococcal infection in HIV-infected patients was not significantly different from that in non-HIV-infected patients.' In the present study, the recurrence rate of pneumococcal bacteremia was higher in HIV-infected patients, although the difference was not statistically significant.
In one study of community-acquired bacteremia in patients with AIDS, many patients presented with normal vital signs, with only 57% of them being febrile on presentation. 23 In published studies of HIV-infected patients with pneumococcal infection, 73 to 86% of the patients had fever at presentation.*5:1G, 24 In the present study, there was no statistically significant difference in vital signs between HIV-infected and non-infected patients.
Leukopenia, hypoalbuminemia, elevated serum lactate dehydrogenase level, low arterial pH, low arterial oxygen tension, and high arterial oxygen tension have been shown to be associated with increased mortality in patients with pneumococcal bacteremia.* In the study by Krumholz et al of AIDS patients with pneumococcal bacteremia, the mean WBC count was 4600/mm3 and 12 (27%) of the 44 cases had leukocyte counts less than 1000/mm3.23 However, five of these patients had recently received chemotherapy for malignancy, and two others had been on zidovudine. Janoff et al reported leukocyte counts less than 5OOO/pL in 44% and leukocytosis in 19% of 16 HIV-infected homosexual men with pneumococcal bacteremia. 24 Pesola and Charles found no difference in leukocyte count between HIV-infected and non-HIV-infected patients. 15 However, in the present study and the study by Garcia-Leoni et al, from Spain, the leukocyte count was lower in HIV-infected patients with pneumococcal infection compared to non-HIVinfected patientsI Pneumonia is the presenting manifestation of pneumococcal bacteremia in the majority of both HIV-infected and non-HIV-infected patients. 3 Pesola and Charles found that AIDS patients with bacteremic pneumococcal pneumonia were more likely to have bilateral infiltrates on chest roentgenograms than HIV-infected patients without AIDS and non-HIV-infected patients. l5 However, since some of their AIDS patients also had Pneumocystis carinii pneumonia, the radiologic findings do not reflect the sole effect of the pneumococcal infectionWhen comparison was made between the non-AIDS HIV-infected and the non-HIV-infected patients in the Pesola and Charles study,lj the radiologic findings were identical. Similar to the study of Garcia-Leoni et aLI6 the present study did not find any significant radiologic differences between the HIV-infected and non-HIV-infected patients, despite higher arterial oxygen tension in the HIV-infected patients.
The reported mortality rates of pneumococcal bacteremia in HIV-infected patients without AIDS are low.3815 In studies by Redd et al and Pesola and Charles, the mortality rate of HIV-infected patients without AIDS was 0 compared to the 18% and 25% mortality rate of the non-HIV-infected patients. 3,15 However, the mortality rate of pneumococcal bacteremia in patients with AIDS has been shown to be as high as 25 to 57%.3,15 The overall mortality rate of pneumococcal bacteremia in HIVinfected patients in the present study was not significantly lower than that in non-HIV-infected patients. Although there are no uniform severity grading systems to compare different studies, the disease severity may explain the high mortality rate. In a previous study, we identified clinical and laboratory findings associated with poor outcome in patients with pneumococcal bacteremia.* The good prognosis associated with younger age and higher arterial oxygen tension of the HIV-infected patients in the present study is counterbalanced by the lower leukocyte count and serum albumin levelThe overall similarity in disease severity between HIV-infected and non-HIV-infected patients in the present study may explain the lack of differences in complication and mortality rates between the two groups. For HIV-infected patients without AIDS, the mortality rate was higher than the mortality rates reported in previous studies.
Although in the present study, the pneumococcal vaccination rate was higher in patients with HIV infection than in those without HIV infection, it was unacceptably low in both groups. Since pneumococcal bacteremia is associated with high complication and mortality rates, more attention should be focused on prevention. The CDC recommends pneumococcal vaccine for patients with HIV infection.z5 Since HIV infected patients mount an appropriate antibody response to pneumococcal vaccination,26-28 vaccine administration can be a cost-effective prevention strategy.29 However, the development of pneumococcal bacteremia in ten patients with HIV infection despite vaccination suggests that vaccination may be less effective in this population.
This study describes the differences between HIVinfected and non-HIV-infected patients with pneumococcal bacteremia. Human immunodeficiency virus infection has emerged as the most common risk factor for pneumococcal bacteremia in patients under 40 years of age. Based on findings by the authors and others, it is recommended that adults under 40 years of age with pneumococcal bacteremia should be evaluated for the presence of HTV infection. Although there were some clinical and laboratory differences between HIV-infected and non-HIV-infected patients with pneumococcal bacteremia, the overall clinical course, including complication and mortality rates, were similar between the two groups. No significant differences in the hospital course was noted between AIDS patients and HKV-infected patients without AIDS with pneumococcal bacteremia.
